Generic drugmakers: states make legally flawed claim

Six drugmakers accused by state attorneys general of price fixing told a federal court in Connecticut on Monday that legal flaws in the complaint against them warrant dismissal of the antitrust case.

Get unlimited access to all Global Competition Review content